id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0139-0010,FDA,FDA-2011-E-0139,Letter from U.S. Patent and Trademark Office to Venable LLP,Other,Letter(s),2014-04-04T04:00:00Z,2014,4,2014-04-04T04:00:00Z,,2014-04-04T19:25:04Z,,0,0,090000648169ef44
FDA-2011-E-0139-0009,FDA,FDA-2011-E-0139,U.S. Patent and Trademark Office to Venable LLP - Letter,Other,Letter(s),2013-11-04T05:00:00Z,2013,11,2013-11-04T05:00:00Z,,2013-11-04T17:38:21Z,,0,0,090000648146fd3e
FDA-2011-E-0139-0008,FDA,FDA-2011-E-0139,U.S. Patent and Trademark Office to JONES DAY - Letter,Other,Letter(s),2013-04-29T04:00:00Z,2013,4,2013-04-29T04:00:00Z,,2013-04-29T12:25:53Z,,0,0,09000064812aa96f
FDA-2011-E-0139-0007,FDA,FDA-2011-E-0139,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:00:15Z,,0,0,090000648119d08b
FDA-2011-E-0139-0006,FDA,FDA-2011-E-0139,Regulatory Review Period for Purposes of Patent Extension: EQUIDONE GEL,Notice,General Notice,2012-05-04T04:00:00Z,2012,5,2012-05-04T04:00:00Z,2012-07-04T03:59:59Z,2012-05-04T13:44:26Z,2012-10853,0,0,0900006481005021
FDA-2011-E-0139-0005,FDA,FDA-2011-E-0139,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-04-18T04:00:00Z,2012,4,2012-04-18T04:00:00Z,,2012-04-18T12:50:34Z,,0,0,0900006480ff338b
FDA-2011-E-0139-0004,FDA,FDA-2011-E-0139,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,Letter(s),2012-01-10T05:00:00Z,2012,1,2012-01-10T05:00:00Z,,2012-01-10T14:25:51Z,,0,0,0900006480f91f09
FDA-2011-E-0139-0003,FDA,FDA-2011-E-0139,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-04-26T04:00:00Z,2011,4,2011-04-26T04:00:00Z,,2011-04-26T18:58:32Z,,0,0,0900006480c39e1e
FDA-2011-E-0139-0001,FDA,FDA-2011-E-0139,"Dechra, Ltd. (Venable LLP) - Patent Extension Application",Other,APP-Application,2011-03-08T05:00:00Z,2011,3,2011-03-08T05:00:00Z,,2013-07-27T23:46:55Z,,0,0,0900006480c033ed
FDA-2011-E-0139-0002,FDA,FDA-2011-E-0139,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-03-08T05:00:00Z,2011,3,2011-03-08T05:00:00Z,,2013-07-27T23:46:55Z,,0,0,0900006480c033f1